BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31327206)

  • 61. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Lennert K
    Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
    Xing PY; Shi YK; He XH; Zhou LQ; Dong M; Yang JL; Liu P
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):692-7. PubMed ID: 23159084
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.
    Papajík T; Mysliveček M; Sedová Z; Buriánková E; Procházka V; Koranda P; Raida L; Kubová Z; Palová M; Kučerová L; Flodr P; Jarkovský J; Dušek L; Indrák K
    Eur J Haematol; 2011 Jan; 86(1):32-7. PubMed ID: 20874822
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical characteristics of and response to combination chemotherapy and subsequent application of international prognostic index in non-Hodgkin's lymphoma--an experience from a medical center in Southern Taiwan.
    Hsieh CI; Su WC; Chien CH; Cuo YL; Chen TY; Kao RH; Tsao CJ
    Kaohsiung J Med Sci; 1996 Feb; 12(2):69-82. PubMed ID: 8709176
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma].
    Wang TT; Li SX; Xia B; Zhao HF; Xu W; Yang HL; Wang XF; Yu Y; Sun BC; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1400-1405. PubMed ID: 28535626
    [No Abstract]   [Full Text] [Related]  

  • 67. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma.
    Niitsu N; Okamato M; Nakamine H; Yoshino T; Tamaru J; Nakamura S; Higashihara M; Hirano M
    Eur J Haematol; 2002 Feb; 68(2):91-100. PubMed ID: 12038454
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Prognostic factors in primary lymphoma of the thyroid--a review of 74 cases].
    Kanetake H; Toda M; Kawamoto Y
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Jul; 96(7):1105-11. PubMed ID: 8366405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Malignant lymphoma: a study of an outpatient cohort].
    Burla M; Egli F; Rhyner K
    Schweiz Rundsch Med Prax; 1990 Jan; 79(5):101-10. PubMed ID: 2305142
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Waldeyer's ring lymphomas: treatment results and prognostic factors.
    Gurkaynak M; Cengiz M; Akyurek S; Ozyar E; Atahan IL; Tekuzman G
    Am J Clin Oncol; 2003 Oct; 26(5):437-40. PubMed ID: 14528067
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis.
    Hou W; Wei P; Xie J; Zheng Y; Zhang Y; Zhou X
    Pathol Res Pract; 2018 Apr; 214(4):513-520. PubMed ID: 29525403
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Prognosis analysis of 53 cases with primary intestinal non-Hodgkin's lymphoma].
    Xiang XJ; He YJ; Li YH; Huang HQ; Xia ZJ; Huang H
    Ai Zheng; 2004 Apr; 23(4):443-7. PubMed ID: 15087036
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Non-Hodgkin's lymphoma of the nasopharynx: CT and MR imaging.
    King AD; Lei KI; Richards PS; Ahuja AT
    Clin Radiol; 2003 Aug; 58(8):621-5. PubMed ID: 12887955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prognostic factors of extranodal non-Hodgkin's lymphoma--an analysis of 62 cases].
    Fu HP
    Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):310-3. PubMed ID: 2272271
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
    Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
    J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Non-Hodgkin lymphomas of the nasopharynx in children--diagnostic and therapeutic difficulties].
    Zawitkowska-Klaczyńska J; Dudkiewicz E; Stefaniak J; Katski K; Bień E; Irga N; Adamkiewicz-Drozyńska E; Płoszyńska A; Stankiewicz C; Balcerska A; Kowalczyk J
    Pol Merkur Lekarski; 2004 Nov; 17(101):471-3. PubMed ID: 15754634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.